2022-RA-459-ESGO UPLIFT (ENGOT-ov67/GOG-3048) a registrational trial of Upifitamab Rilsodotin (XMT-1536; UpRi), a NaPi2b-directed antibody drug conjugate (ADC) in platinum-resistant ovarian cancer

Authors :: Nicole Concin
Bradley J Monk
Mansoor Raza Mirza
Robert L Coleman
Isabelle Ray-Coquard
Bhavana Pothuri
Jean-Francois Baurain
J Alejandro Perez-Fidalgo
David Cibula
Antonella Saverse
Susana Banerjee
Radek Madry
Christian Marth
Emily Putiri
Jamie Barrett
Leslie DeMars
Debra Richardson
Source :: Ovarian cancer.
Publication Year :: 2022
Publisher :: BMJ Publishing Group Ltd, 2022.

Full Text Access

Tools